| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/26/2004 | EP1422295A1 Method for modifying chromosomes |
| 05/26/2004 | EP1422294A1 Method of making an HPV18 L1 Expression Vector and HPV18 L1,L2 antibodies |
| 05/26/2004 | EP1422243A1 HUMANIZED ANTIBODY AGAINST FIBROBLAST GROWTH FACTOR−8 AND FRAGMENT OF THE ANTIBODY |
| 05/26/2004 | EP1422238A2 Leishmania antigens for use in the therapy and diagnosis of leishmaniasis |
| 05/26/2004 | EP1422237A2 Methods for the recombinant production of antifusogenic peptides |
| 05/26/2004 | EP1421951A2 Conserved motif of hepatitis C virus E2/NS1 region |
| 05/26/2004 | EP1421539A2 Stabilized proteins with engineered disulfide bonds |
| 05/26/2004 | EP1421391A2 Sodium channel regulators and modulators |
| 05/26/2004 | EP1421388A2 Diagnosis of carcinomas |
| 05/26/2004 | EP1421385A1 Genetic construct intracellular monitoring system |
| 05/26/2004 | EP1421384A2 Hprp4s as modifiers of the p53 pathway and methods of use |
| 05/26/2004 | EP1421383A2 Method to identify modulators for human 3-alpha-hydroxysteroid dehydrogenase |
| 05/26/2004 | EP1421377A2 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 05/26/2004 | EP1421224A2 Polypeptides having cellobiohydrolase i activity and polynucleotides encoding same |
| 05/26/2004 | EP1421222A2 Cell culture system for synthesis of infectious hepatitis c virus |
| 05/26/2004 | EP1421220A2 Method and nucleic acids for the analysis of colon cancer |
| 05/26/2004 | EP1421219A2 Use of associations between at least one nucleic sequence polymorphism of the sh2 gene and at least one seed quality characteristic in plant selection methods |
| 05/26/2004 | EP1421218A2 Model of autoimmune disease and methods for identifying agents against autoimmune disease |
| 05/26/2004 | EP1421216A1 Method for manufacturing hydrogel biochip by using star-like polyethylene glycol derivative having epoxy group |
| 05/26/2004 | EP1421215A2 Methods for evaluating pathologic conditions using extracellular rna |
| 05/26/2004 | EP1421214A2 Amplified oncogenes and their involvement in cancer |
| 05/26/2004 | EP1421213A2 Labeled nucleoside polyphosphates |
| 05/26/2004 | EP1421211A2 Methods for detecting dna originating from different individuals |
| 05/26/2004 | EP1421210A2 Method of detecting protease activity in a cell |
| 05/26/2004 | EP1421207A2 Method for the detection of cytochrome b mutations in fungi |
| 05/26/2004 | EP1421203A2 Novel antigen binding molecules for therapeutic, diagnostic, prophylactic, enzymatic, industrial, and agricultural applications, and methods for generating and screening thereof |
| 05/26/2004 | EP1421202A2 Method for producing vitamin b12 |
| 05/26/2004 | EP1421201A2 Methods for immobilizing molecules to a solid phase and uses thereof |
| 05/26/2004 | EP1421200A2 Fluorescent multiplex hpv pcr assays using multiple fluorophores |
| 05/26/2004 | EP1421199A2 Compositions and methods for treating neurodegenerative diseases |
| 05/26/2004 | EP1421198A2 Cell-based high-throughput screening methods |
| 05/26/2004 | EP1421197A2 Caax prenyl protease nucleic acids and polypeptides and methods of use thereof |
| 05/26/2004 | EP1421196A2 Rice regulatory sequences for gene expression in defined wheat tissue |
| 05/26/2004 | EP1421195A1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 05/26/2004 | EP1421194A1 Regulation of human dcamkl1-like serine/threonine protein kinase |
| 05/26/2004 | EP1421193A2 Novel metabolism-associated gene products of ashbya gossypii |
| 05/26/2004 | EP1421192A1 Regulation of human ptpase-like protein |
| 05/26/2004 | EP1421191A2 Therapeutic binding molecules |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421189A2 Method and device for integrated protein expression, purification and detection |
| 05/26/2004 | EP1421187A2 Systems for in vivo site-directed mutagenesis using oligonucleotides |
| 05/26/2004 | EP1421184A2 Live attenuated strains of prrs virus |
| 05/26/2004 | EP1421183A2 Methods for improving seed and grain characteristics |
| 05/26/2004 | EP1421182A1 Methods of inducing differentiation of stem cells |
| 05/26/2004 | EP1421177A2 Zinc finger binding domains for cnn |
| 05/26/2004 | EP1421176A2 Nucleic acids and encoded polypeptides associated with bipolar disorder |
| 05/26/2004 | EP1421175A2 Polymer stabilized proteinases |
| 05/26/2004 | EP1421174A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 05/26/2004 | EP1421117A2 Compositions and methods for generating chimeric heteromultimers |
| 05/26/2004 | EP1421115A2 Soluble t cell receptor |
| 05/26/2004 | EP1421112A1 Novel serine protease |
| 05/26/2004 | EP1421111A2 Proteins associated with cell growth differentiation, and death |
| 05/26/2004 | EP1421110A2 Novel genetic products from ashbya gossypii, associated with the structure of the cell wall or the cytoskeleton |
| 05/26/2004 | EP1421109A2 Non-mammalian gnrh analogs and uses thereof in regulation of fertility and pregnancy |
| 05/26/2004 | EP1421103A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421102A2 Method for making acylated polypeptides |
| 05/26/2004 | EP1421101A2 P-glycoproteins and uses thereof |
| 05/26/2004 | EP1421098A2 Surface proteins of streptococcus pyogenes |
| 05/26/2004 | EP1421097A2 Compositions and methods relating to the daptomycin biosynthetic gene cluster |
| 05/26/2004 | EP1421096A2 CONSTITUTIVE PHOTOMORPHOGENESIS 1 (COP1) NUCLEIC ACID SEQUENCE FROM i ZEA MAYS /i AND ITS USE THEREOF |
| 05/26/2004 | EP1421095A1 Assay for detection of human parvovirus b19 nucleic acid |
| 05/26/2004 | EP1420879A2 Treatment of substrates using an electrochemical method |
| 05/26/2004 | EP1420821A2 Immunologically significant herpes simplex virus antigens and methods for using same |
| 05/26/2004 | EP1420819A1 Sub-unit vaccine for infectious pancreatic necrosis virus |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420816A2 Uses of mammalian cytokine; related reagents |
| 05/26/2004 | EP1420815A2 Beta-amyloid-analogue - t-cell epitop vaccine |
| 05/26/2004 | EP1420814A2 Compositions and methods for the therapy and diagnosis of breast cancer |
| 05/26/2004 | EP1420813A1 Pregnancy-related enzyme activity |
| 05/26/2004 | EP1420810A1 Modulation of leukocyte-endothelial interactions following ischemia |
| 05/26/2004 | EP1420803A1 Method for amplifying expression from a cell specific promoter |
| 05/26/2004 | EP1420800A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 05/26/2004 | EP1420748A2 Peg-modified uricase |
| 05/26/2004 | EP1420643A2 Enhancement of transfection of dna into the liver |
| 05/26/2004 | EP1420637A2 Transgenic rodents as animal models for modulation of b 1? bradykinin receptor protein |
| 05/26/2004 | EP1420636A2 Mycoplasma bovis challenge model, methods for administering m. bovis and methods for inducing pneumonic lung lesions |
| 05/26/2004 | EP1420635A1 Development of transgenic model for interventions in neurodegenerative diseases |
| 05/26/2004 | EP1420631A1 Plant-derived resistance gene |
| 05/26/2004 | EP1420630A2 Stress-related polynucleotides and polypeptides in plants |
| 05/26/2004 | EP1420629A2 Wheat plants having increased resistance to imidazolinone herbicides |
| 05/26/2004 | EP1349952A4 Infection resistant plants and methods for their generation |
| 05/26/2004 | EP1222029B1 Substrate with at least one pore |
| 05/26/2004 | EP1127142A4 Modulation of polypeptide display on modified filamentous phage |
| 05/26/2004 | EP1104475B1 C-myc is activated by beta-catenin and tcf-4 |
| 05/26/2004 | EP1088106B1 Polymerase signaling assay |
| 05/26/2004 | EP1083927B1 HUMAN MINOR VAULT PROTEIN p193 |
| 05/26/2004 | EP1011311A4 Controlled germination using inducible phytate gene |
| 05/26/2004 | EP0977838B1 H2-o modified transgenic animals |
| 05/26/2004 | EP0894129B1 Short external guide sequences |
| 05/26/2004 | EP0888125B1 GLYCOSYLATED IgG ANTIBODIES |
| 05/26/2004 | EP0812331B1 Mhc-antigen complexes for detecting and purifying antigen-specific t cells |
| 05/26/2004 | EP0805851B1 Binary bac vector |
| 05/26/2004 | EP0751781B1 Use of monoclonal antibodies or soluble oligomeric ligands in the manufacture of a medicament for the prevention or treatment of neoplastic disorders |
| 05/26/2004 | EP0672752B1 Method of transforming monocotyledon by using scutellum of immature embryo |
| 05/26/2004 | CN1500152A Nucleic acid vaccines for prevention of flavivirus infection |
| 05/26/2004 | CN1500151A PCR method |
| 05/26/2004 | CN1500150A Methods for amplifying and detecting multiple polynucleotides on solid phase support |
| 05/26/2004 | CN1500149A Methods and kits for identifing scavengers of reactive oxygen species (Ros) |
| 05/26/2004 | CN1500148A Methods for prodn. of products in host cells |
| 05/26/2004 | CN1500147A Improved gene expression |